NCT02191358 - YouScript IMPACT Registry | Biotech Hunter

Enrollment

800

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Adverse Drug EventsAdverse Drug ReactionsDrug Interaction PotentiationDrug Metabolism, Poor, CYP2D6-RELATEDDrug Metabolism, Poor, CYP2C19-RELATEDCytochrome P450 Enzyme DeficiencyCytochrome P450 CYP2D6 Enzyme DeficiencyCytochrome P450 CYP2C9 Enzyme DeficiencyCytochrome P450 CYP2C19 Enzyme DeficiencyCytochrome P450 CYP3A Enzyme DeficiencyPoor Metabolizer Due to Cytochrome P450 CYP2C9 VariantPoor Metabolizer Due to Cytochrome P450 CYP2C19 VariantPoor Metabolizer Due to Cytochrome P450 CYP2D6 Variant

Trial Locations (7)

21204

IRC Clinics, Towson

24073

Carilion Clinic, Christiansburg

40508

Gill Heart Institute, Lexington

80011

Kaiser Permanente Colorado, Denver

92844

Dr. Michael Dao, Garden Grove

02720

Internal Medicine & Cardiology Associates, Fall River

Prima CARE, Fall River